Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
Abstract Genotype-informed anticancer therapies such as BRAF inhibitors can show remarkable clinical efficacy in BRAF-mutant melanoma; however, drug resistance poses a major hurdle to successful cancer treatment. Many resistance events to targeted therapies have been identified, suggesting a complex...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-86694-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832585851672985600 |
---|---|
author | Li Chen Iulian Pruteanu-Malinici Anahita Dastur Xunqin Yin Dennie Frederick Ruslan I. Sadreyev Cyril H. Benes |
author_facet | Li Chen Iulian Pruteanu-Malinici Anahita Dastur Xunqin Yin Dennie Frederick Ruslan I. Sadreyev Cyril H. Benes |
author_sort | Li Chen |
collection | DOAJ |
description | Abstract Genotype-informed anticancer therapies such as BRAF inhibitors can show remarkable clinical efficacy in BRAF-mutant melanoma; however, drug resistance poses a major hurdle to successful cancer treatment. Many resistance events to targeted therapies have been identified, suggesting a complex path to improve therapeutics. Here, we showed the utility of a piggyBac transposon activation mutagenesis screen for the efficient identification of genes that are resistant to BRAF inhibition in melanoma. Although several forward genetic screens performed in the same context have identified a broad range of resistance genes that poorly overlap, an integrative analysis revealed a much smaller functional diversity of resistance mechanisms, including reactivation of the MAPK pathway, PI3K-AKT pathway, and Hippo pathway, suggesting that a relatively small number of therapeutic strategies might overcome resistance manifested by a large gene set. Moreover, we illustrated the pivotal role of the Hippo pathway effector TAZ (encoded by the WWTR1 gene) in mediating BRAF inhibition resistance through transcriptional regulation of receptor tyrosine kinases and through interactions with the E3 ubiquitin ligase NEDD4L. |
format | Article |
id | doaj-art-7d1d6ee315774d589b0cd6f455ff8219 |
institution | Kabale University |
issn | 2045-2322 |
language | English |
publishDate | 2025-01-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj-art-7d1d6ee315774d589b0cd6f455ff82192025-01-26T12:25:59ZengNature PortfolioScientific Reports2045-23222025-01-0115111210.1038/s41598-025-86694-5Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation eventsLi Chen0Iulian Pruteanu-Malinici1Anahita Dastur2Xunqin Yin3Dennie Frederick4Ruslan I. Sadreyev5Cyril H. Benes6Massachusetts General Hospital Cancer Center, Harvard Medical SchoolMassachusetts General Hospital Cancer Center, Harvard Medical SchoolMassachusetts General Hospital Cancer Center, Harvard Medical SchoolMassachusetts General Hospital Cancer Center, Harvard Medical SchoolMassachusetts General Hospital Cancer Center, Harvard Medical SchoolDepartment of Molecular Biology, Massachusetts General Hospital, Harvard Medical SchoolMassachusetts General Hospital Cancer Center, Harvard Medical SchoolAbstract Genotype-informed anticancer therapies such as BRAF inhibitors can show remarkable clinical efficacy in BRAF-mutant melanoma; however, drug resistance poses a major hurdle to successful cancer treatment. Many resistance events to targeted therapies have been identified, suggesting a complex path to improve therapeutics. Here, we showed the utility of a piggyBac transposon activation mutagenesis screen for the efficient identification of genes that are resistant to BRAF inhibition in melanoma. Although several forward genetic screens performed in the same context have identified a broad range of resistance genes that poorly overlap, an integrative analysis revealed a much smaller functional diversity of resistance mechanisms, including reactivation of the MAPK pathway, PI3K-AKT pathway, and Hippo pathway, suggesting that a relatively small number of therapeutic strategies might overcome resistance manifested by a large gene set. Moreover, we illustrated the pivotal role of the Hippo pathway effector TAZ (encoded by the WWTR1 gene) in mediating BRAF inhibition resistance through transcriptional regulation of receptor tyrosine kinases and through interactions with the E3 ubiquitin ligase NEDD4L.https://doi.org/10.1038/s41598-025-86694-5BRAF inhibitor resistanceTransposon mutagenesis screenHippo pathwayTAZNEDD4L |
spellingShingle | Li Chen Iulian Pruteanu-Malinici Anahita Dastur Xunqin Yin Dennie Frederick Ruslan I. Sadreyev Cyril H. Benes Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events Scientific Reports BRAF inhibitor resistance Transposon mutagenesis screen Hippo pathway TAZ NEDD4L |
title | Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events |
title_full | Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events |
title_fullStr | Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events |
title_full_unstemmed | Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events |
title_short | Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events |
title_sort | transposon mediated functional genomic screening for braf inhibitor resistance reveals convergent hippo and mapk pathway activation events |
topic | BRAF inhibitor resistance Transposon mutagenesis screen Hippo pathway TAZ NEDD4L |
url | https://doi.org/10.1038/s41598-025-86694-5 |
work_keys_str_mv | AT lichen transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents AT iulianpruteanumalinici transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents AT anahitadastur transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents AT xunqinyin transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents AT denniefrederick transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents AT ruslanisadreyev transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents AT cyrilhbenes transposonmediatedfunctionalgenomicscreeningforbrafinhibitorresistancerevealsconvergenthippoandmapkpathwayactivationevents |